Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
Taiwan
· Delayed Price · Currency is TWD 71.50
+1.20 (1.71%)
Apr 2, 2025, 1:30 PM CST
TPEX:4747 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 611.42 | 606.71 | 494.67 | 411.49 | 424.02 | Upgrade
|
| Revenue Growth (YoY) | 0.78% | 22.65% | 20.21% | -2.95% | -0.31% | Upgrade
|
| Cost of Revenue | 363.45 | 362.08 | 290.29 | 239.57 | 231.83 | Upgrade
|
| Gross Profit | 247.97 | 244.63 | 204.38 | 171.92 | 192.18 | Upgrade
|
| Selling, General & Admin | 129.21 | 128.45 | 108.45 | 100.72 | 103.57 | Upgrade
|
| Research & Development | 20.76 | 17.27 | 13.25 | 8.92 | 13.08 | Upgrade
|
| Operating Expenses | 149.77 | 145.8 | 122.58 | 109.64 | 116.17 | Upgrade
|
| Operating Income | 98.2 | 98.83 | 81.79 | 62.29 | 76.01 | Upgrade
|
| Interest Expense | -3.51 | -4.6 | -1.06 | -1.08 | -0.79 | Upgrade
|
| Interest & Investment Income | 13.24 | 6.33 | 0.49 | 0.57 | 0.99 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.04 | 0.1 | -0.66 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.78 | 0.28 | 0.21 | 0.83 | 0.33 | Upgrade
|
| EBT Excluding Unusual Items | 108.71 | 100.88 | 81.53 | 61.95 | 76.51 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.01 | - | -0.01 | 0.05 | Upgrade
|
| Pretax Income | 108.71 | 100.89 | 81.53 | 61.94 | 76.55 | Upgrade
|
| Income Tax Expense | 24.59 | 21.19 | 16.68 | 12.84 | 12.99 | Upgrade
|
| Net Income | 84.12 | 79.7 | 64.85 | 49.1 | 63.56 | Upgrade
|
| Net Income to Common | 84.12 | 79.7 | 64.85 | 49.1 | 63.56 | Upgrade
|
| Net Income Growth | 5.55% | 22.90% | 32.08% | -22.75% | -1.41% | Upgrade
|
| Shares Outstanding (Basic) | 45 | 36 | 30 | 30 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 45 | 38 | 30 | 30 | 30 | Upgrade
|
| Shares Change (YoY) | 19.09% | 26.25% | -0.07% | -0.04% | 0.01% | Upgrade
|
| EPS (Basic) | 1.87 | 2.24 | 2.16 | 1.64 | 2.12 | Upgrade
|
| EPS (Diluted) | 1.86 | 2.18 | 2.16 | 1.63 | 2.11 | Upgrade
|
| EPS Growth | -14.64% | 0.88% | 32.52% | -22.75% | -1.40% | Upgrade
|
| Free Cash Flow | 49.68 | 103.84 | 29.98 | 15.06 | -90.41 | Upgrade
|
| Free Cash Flow Per Share | 1.10 | 2.73 | 1.00 | 0.50 | -3.00 | Upgrade
|
| Dividend Per Share | - | 1.498 | 2.000 | 1.450 | 1.920 | Upgrade
|
| Dividend Growth | - | -25.08% | 37.93% | -24.48% | 6.67% | Upgrade
|
| Gross Margin | 40.56% | 40.32% | 41.32% | 41.78% | 45.32% | Upgrade
|
| Operating Margin | 16.06% | 16.29% | 16.54% | 15.14% | 17.93% | Upgrade
|
| Profit Margin | 13.76% | 13.14% | 13.11% | 11.93% | 14.99% | Upgrade
|
| Free Cash Flow Margin | 8.13% | 17.11% | 6.06% | 3.66% | -21.32% | Upgrade
|
| EBITDA | 119.17 | 119.94 | 100.06 | 77.57 | 89.24 | Upgrade
|
| EBITDA Margin | 19.49% | 19.77% | 20.23% | 18.85% | 21.05% | Upgrade
|
| D&A For EBITDA | 20.97 | 21.11 | 18.27 | 15.29 | 13.23 | Upgrade
|
| EBIT | 98.2 | 98.83 | 81.79 | 62.29 | 76.01 | Upgrade
|
| EBIT Margin | 16.06% | 16.29% | 16.54% | 15.14% | 17.93% | Upgrade
|
| Effective Tax Rate | 22.62% | 21.00% | 20.46% | 20.73% | 16.97% | Upgrade
|
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.